0
Pulmonary Rehabilitation |

Yoga Is as Effective as Standard Pulmonary Rehabilitation in Improving Dyspnea, Inflammatory Markers, and Quality of Life in Patients With COPD

Randeep Guleria, DM; Sneh Arora, PhD; Anant Mohan, MD; Guresh Kumar, PhD; Ajit Kumar
Author and Funding Information

All India Institute of Medical Sciences, New Delhi, India


Chest. 2015;148(4_MeetingAbstracts):907A. doi:10.1378/chest.2266469
Text Size: A A A
Published online

Abstract

SESSION TITLE: Pulmonary Rehabilitation

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Monday, October 26, 2015 at 07:30 AM - 08:30 AM

PURPOSE: The effectiveness of yoga as a form of rehabilitation therapy as compared to pulmonary rehabilitation in COPD is unclear. We investigated to see whether yoga was as effective as standard pulmonary rehabilitation on inflammatory markers, dyspnoea and quality of life in patients with COPD.

METHODS: 60 patients with COPD were randomly divided into 2 groups. One group (group 1) was taught yoga exercises including asanas , pranayam , meditation and relaxation technique. The second group (group 2) underwent pulmonary rehabilitation. Both groups underwent one hour of training twice a week for the first 4 weeks. For the remaining 8 weeks the supervised session was fortnightly and the remaining sessions were at home.Baseline evaluation for both group included lung functions, dyspnoea assessment (Borg scale, VAS, six minute walk test), quality of life (QOL) and serum inflammatory markers ( CRP and Il-6). Repeat assessment of all these parameters was done at the end of 12 weeks in both groups.

RESULTS: Median level of CRP and Il-6 in group 1 at base line was 1.0(0.0-12.0) mg/dl, 23.10 (5.48-170.03) pg/ml respectively. Median level of CRP and Il-6 in group 2 at base line was 1.15(0-14.0) mg/dl and 6.65(.06-80.02) pg/ml respectively. Median level of CRP and Il-6 in group 1 after 12 weeks was .70(0.10-10.0) mg/dl, 32.74(0.50-206.00) pg/ml respectively. Median level of CRP and Il-6 in group 2 after 12 weeks was .80(0.3-6.6) mg/dl, 36.28(6.88-198.03) pg/ml respectively. Mean values of 6MWT, Borg scale and VAS in group 1 at baseline was 419.0±128.12 meters, 1.50(0.5-7.0), 55.17±8.55mm and after 12 weeks was 456.43±91.41meters, 1.0 (0.0-4.0), 70.36±8.81 mm respectively. Mean values of 6MWT, Borg scale and VAS in group 2 at baseline was 391.88±113.10 meters, 3.00(0.0-7.0) 49.67±17.61mm and after 12 weeks was 424.66±78.21meters, .50(0.0-7.0), 67.24±17.55 mm respectively. There was significant improvement in these parameters in both groups. The QOL at 12 weeks showed significant change from baseline value in group 1. The QOL score showed a non significant change at 12 weeks from baseline in group 2.

CONCLUSIONS: Yoga and PMR exercises done in a structured manner result in similar improvement in pulmonary functions, 6 minute walk distance, Borg scale, severity of dyspnoea, quality of life and levels of C-reactive protein after 12 weeks of training.

CLINICAL IMPLICATIONS: Yoga is a cost-effective form of rehabilitation and is as effective as a standard PMR. Yoga programs can be adopted as integral part of long term management of COPD.

DISCLOSURE: The following authors have nothing to disclose: Randeep Guleria, Sneh Arora, Anant Mohan, Guresh Kumar, Ajit Kumar

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543